Document is current
Any future updates will be listed below
-
Authors
Johnson, Melissa
Hong, David
Braña, Irene
Schöffski, Patrick
Galvao, Vladimir
Rangwala, Fatima
Ma, Bo
Hernandez, Robert
Kamat, Asha
Kato, Kazunobu
Schreiber, Taylor H.
Pandite, Lini
Siu, Lillian L.
-
Funding
Funding for this research was provided by:
Shattuck Labs (NA)
- License Information
-
More Information
Article History
Received: 9 January 2025
Accepted: 14 February 2025
First Online: 5 March 2025
Declarations
:
: The study involves human participants. Ethical approval was obtained for this study from IntegReview IRB (SL01-DEL-101 (RM 619); Sarah Cannon Research Institute); MDACC IRB, (study number 2018 − 1078, MD Anderson Cancer Center); UHN REB (study number 19-5155, Princess Margaret Hospital); UZ Lueven EC (study number S62574, University Hospital Leuven) and Vall d’Hebron University Hospital REC (Study number, SL01-DEL-101, Vall d’Hebron University). All participants provided written informed consent to participate in the study before taking part.
: This study was conducted in full conformity with the Declaration of Helsinki and was approved by all Institutional Review Boards/ethics committees from each clinical site participating in the study. All patients provided written informed consent in accordance with ICH/GCP guidelines and applicable local regulations prior to study initiation.
: Not applicable.
: This study was funded by Shattuck Labs. Some of the authors are Shattuck Lab employees or were former employees of Shattuck Labs. The COI for each of the authors is provided in the manuscript.
